in.finance.yahoo.com
Aurobindo Pharma: Stock has factored in import alert
Assuming worst-case scenario, ARBP announced that the USFDA issued a form-483 for its Unit-VII, its largest orals facility for the US, though, increasingly less relevant for future pipeline/filings, particularly, post Sandoz deal closure.